- Home
- BMRN vs ASR Comparison
BMRN vs ASR Comparison
Compare BMRN & ASR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BMRN
- ASR
- Stock Information
- Founded
- BMRN 1996
- ASR 1996
- Country
- BMRN United States
- ASR Mexico
- Employees
- BMRN N/A
- ASR N/A
- Industry
- BMRN Biotechnology: Pharmaceutical Preparations
- ASR Aerospace
- Sector
- BMRN Health Care
- ASR Consumer Discretionary
- Exchange
- BMRN Nasdaq
- ASR Nasdaq
- Market Cap
- BMRN 10.0B
- ASR 9.7B
- IPO Year
- BMRN 1999
- ASR 2000
- Fundamental
- Price
- BMRN $52.47
- ASR N/A
- Analyst Decision
- BMRN Buy
- ASR Buy
- Analyst Count
- BMRN 18
- ASR 2
- Target Price
- BMRN $93.71
- ASR $310.00
- AVG Volume (30 Days)
- BMRN 2.2M
- ASR 87.0K
- Earning Date
- BMRN 10-28-2025
- ASR 10-22-2025
- Dividend Yield
- BMRN N/A
- ASR 9.85%
- EPS Growth
- BMRN 154.69
- ASR 3.79
- EPS
- BMRN 3.40
- ASR 2.20
- Revenue
- BMRN $3,063,608,000.00
- ASR $1,803,288,586.00
- Revenue This Year
- BMRN $13.35
- ASR $14.70
- Revenue Next Year
- BMRN $9.18
- ASR $10.24
- P/E Ratio
- BMRN $15.44
- ASR $14.19
- Revenue Growth
- BMRN 18.36
- ASR 21.26
- 52 Week Low
- BMRN $51.57
- ASR $248.88
- 52 Week High
- BMRN $73.51
- ASR $360.00
- Technical
- Relative Strength Index (RSI)
- BMRN 38.26
- ASR 34.26
- Support Level
- BMRN $51.79
- ASR $308.95
- Resistance Level
- BMRN $55.39
- ASR $317.00
- Average True Range (ATR)
- BMRN 1.36
- ASR 8.25
- MACD
- BMRN -0.11
- ASR -2.23
- Stochastic Oscillator
- BMRN 19.28
- ASR 5.82
About BMRN BioMarin Pharmaceutical Inc.
BioMarin is a global biotechnology company focused on developing and commercializing therapies for rare genetic diseases. BioMarin specializes in enzyme replacement therapies, gene therapies, and other advanced treatments designed to address complex genetic disorders. The company has eight approved therapies for conditions including achondroplasia, phenylketonuria, hemophilia, and mucopolysaccharidosis. BioMarin has an expanding, yet relatively early-stage, pipeline of treatments in development across skeletal conditions and enzyme therapies.
About ASR Grupo Aeroportuario del Sureste S.A. de C.V.
Grupo Aeroportuario del Sureste SAB de CV and its subsidiaries hold concessions to operate, maintain, and develop airports in the southeast region of Mexico. As an operator of airports, it charges airlines, passengers, and other users fees for using the airports' facilities. The group also derives rental and other income from commercial activities conducted at its airports, such as the leasing of space to restaurants and retailers. The group's operating segments are Cancun, which generates maximum revenue, Aerostar, Airplan, Merida, Villahermosa, Holding and Services, and Others.